TNX-601 ER, Tianeptine Hemioxalate, is an Extended-Release Tablet for Once-a-Day Dosing
Phase 2 Clinical Trial of TNX-601 ER Expected to Start First Quarter 2023
https://finance.yahoo.com/news/tonix-pharmaceuticals-announces-ind-clearance-110000875.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.